Drugs / R-5280
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT06057454 Comparator | Dec 2023 → Nov 2025 | type 1 diabetes mellitus | Rise Therapeutics LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | R-5280 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06057454 ↗ |
| Route | Oral | “orally with food” NCT06057454 ↗ |